Metastatic breast neoplasm
Showing 1 - 25 of >10,000
Breast Cancer, Metastatic Breast Cancer, Breast Tumor Trial in Port Jefferson Station (SV-BR-1-GM, Cyclophosphamide, Interferon
Not yet recruiting
- Breast Cancer
- +4 more
- SV-BR-1-GM
- +4 more
-
Port Jefferson Station, New YorkNew York Cancers & Blood Specialists
Oct 2, 2023
Luminal Metastatic breAst caNcer in Real-life Clinical pracTice
Completed
- HR+/HER2- Breast Cancer
- +2 more
-
Moscow, Russian FederationRussian Society of Clinical Oncology
Mar 29, 2023
Metastatic Breast Cancer, Brain Metastases Trial in Tampa (Nivolumab, Stereotactic Radiosurgery)
Active, not recruiting
- Metastatic Breast Cancer
- Brain Metastases
- Nivolumab
- Stereotactic Radiosurgery
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Nov 17, 2022
PROVIDENCE - Real-world Study in HER2-positive Unresectable or
Not yet recruiting
- Breast Neoplasms
- +2 more
- (no location specified)
Oct 7, 2022
Breast Cancer Metastatic, Leptomeningeal Metastasis Trial (Tucatinib Oral Tablet, Capecitabine tablets, Trastuzumab Injection)
Not yet recruiting
- Breast Cancer Metastatic
- Leptomeningeal Metastasis
- Tucatinib Oral Tablet
- +2 more
- (no location specified)
Mar 23, 2023
Breast Cancer, Oligometastasis, Metastatic Breast Cancer Trial in Tokyo (Systemic therapy for 12 weeks after primary
Recruiting
- Breast Cancer
- +2 more
- Systemic therapy for 12 weeks after primary registration
- +3 more
-
Tokyo, JapanTokyo Medical and Dental Univetsity
Nov 15, 2023
Breast Cancer, Metastatic Breast Cancer Trial (Trastuzumab-Deruxtecan (T-DXd))
Not yet recruiting
- Breast Cancer
- Metastatic Breast Cancer
- Trastuzumab-Deruxtecan (T-DXd)
- (no location specified)
Sep 20, 2023
Metastatic Colorectal Cancer, Metastatic Pancreatic Cancer, Metastatic Ovarian Cancer Trial run by the National Cancer Institute
Recruiting
- Metastatic Colorectal Cancer
- +4 more
- Young TIL
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Metastatic HER2 Negative Breast Carcinoma, Brain Metastases, Capecitabine Trial in Changsha (UTD1 combined with capecitabine)
Recruiting
- Metastatic HER2 Negative Breast Carcinoma
- +3 more
- UTD1 combined with capecitabine
-
Changsha, ChinaQuchang Ouyang
Sep 9, 2022
Breast Tumor, Metastatic Breast Cancer, Rb+ Breast Cancer Trial in Philadelphia ([18F]FLT, PET/CT, ribociclib)
Active, not recruiting
- Breast Neoplasm
- +2 more
- [18F]FLT
- +3 more
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania Hospital
Aug 16, 2022
Metastatic Breast Cancer, Advanced Non-Small Cell Squamous Lung Cancer, Solid Tumor, Adult Trial (Patritumab deruxtecan)
Not yet recruiting
- Metastatic Breast Cancer
- +2 more
- Patritumab deruxtecan
- (no location specified)
May 9, 2023
Breast Tumor Female, Metastatic Breast Cancer Trial in Olomouc (Disulfiram)
Recruiting
- Breast Neoplasm Female
- Metastatic Breast Cancer
-
Olomouc, CzechiaUniversity Hospital Olomouc
Aug 2, 2022
Breast Tumors, Tumor Metastasis Trial in Boston, Canton (CodaLytic)
Not yet recruiting
- Breast Neoplasms
- Neoplasm Metastasis
- CodaLytic
-
Boston, Massachusetts
- +1 more
Oct 28, 2022
Advanced Solid Tumor, Advanced Breast Cancer, Metastatic Breast Cancer Trial (BGB-43395, Fulvestrant, Letrozole)
Not yet recruiting
- Advanced Solid Tumor
- +8 more
- BGB-43395
- +2 more
- (no location specified)
Nov 13, 2023
Breast Cancer, Tumor Metastasis Trial in Houston (Trastuzumab, RAD001)
Completed
- Breast Cancer
- Neoplasm Metastasis
-
Houston, TexasUT MD Anderson Cancer Center
Sep 30, 2022
Metastatic Malignant Tumor in the Bone, Stage IV Breast Cancer AJCC v6 and v7, Triple-Negative Breast Carcinoma Trial in
Active, not recruiting
- Metastatic Malignant Neoplasm in the Bone
- +2 more
- Laboratory Biomarker Analysis
- +2 more
-
Scottsdale, ArizonaMayo Clinic in Arizona
Jan 4, 2023
Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Refractory Malignant Solid Tumor Trial in Boston, Galveston,
Suspended
- Advanced Malignant Solid Neoplasm
- +4 more
- BET Bromodomain Inhibitor ZEN-3694
- Binimetinib
-
Boston, Massachusetts
- +2 more
Oct 5, 2022
Estrogen Receptor Positive Breast Cancer, Breast Tumor, Metastatic Breast Cancer Trial in Philadelphia ([18F]FES)
Active, not recruiting
- Estrogen Receptor Positive Breast Cancer
- +2 more
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania Hospital
Jul 5, 2022
Breast Cancer, HER2-positive Breast Cancer, Triple Negative Breast Cancer Trial in Boston (MRI)
Recruiting
- Breast Cancer
- +5 more
- MRI
-
Boston, MassachusettsBrigham and Women's Hospital
Dec 9, 2022
Breast Tumor Female, Quality of Life Trial in São Paulo (Use of the WeCancer app combined with the smartwatch.)
Recruiting
- Breast Neoplasm Female
- Quality of Life
- Use of the WeCancer app combined with the smartwatch.
-
São Paulo, Brazil
- +1 more
Aug 8, 2022
Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Metastatic Malignant Tumor in the Leptomeninges Trial in
Not yet recruiting
- Anatomic Stage IV Breast Cancer AJCC v8
- +2 more
- Digital Photography
- +3 more
-
Jacksonville, FloridaMayo Clinic in Florida
Feb 28, 2023
Brain Metastases, HR+ Metastatic Breast Cancer Trial in Tampa (Stereotactic Radiosurgery (SRS), Abemaciclib, Endocrine therapy)
Recruiting
- Brain Metastases
- HR+ Metastatic Breast Cancer
- Stereotactic Radiosurgery (SRS)
- +2 more
-
Tampa, FloridaMoffitt Cancer Center
Nov 1, 2022